HEALTHY CHOICE WELLNESS CORP (HCWC) Fundamental Analysis & Valuation

NYSEARCA:HCWC • US42227T1051

0.2889 USD
+0 (+1.69%)
At close: Mar 11, 2026
0.2991 USD
+0.01 (+3.53%)
After Hours: 3/11/2026, 4:04:07 PM

This HCWC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

HCWC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 38 industry peers in the Consumer Staples Distribution & Retail industry. HCWC may be in some trouble as it scores bad on both profitability and health. HCWC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. HCWC Profitability Analysis

1.1 Basic Checks

  • In the past year HCWC has reported negative net income.
  • In the past year HCWC had a positive cash flow from operations.
HCWC Yearly Net Income VS EBIT VS OCF VS FCFHCWC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M -8M

1.2 Ratios

  • HCWC's Return On Assets of -8.38% is on the low side compared to the rest of the industry. HCWC is outperformed by 84.21% of its industry peers.
  • HCWC has a worse Return On Equity (-47.80%) than 78.95% of its industry peers.
Industry RankSector Rank
ROA -8.38%
ROE -47.8%
ROIC N/A
ROA(3y)-19.39%
ROA(5y)N/A
ROE(3y)-107.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HCWC Yearly ROA, ROE, ROICHCWC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

  • With an excellent Gross Margin value of 39.73%, HCWC belongs to the best of the industry, outperforming 86.84% of the companies in the same industry.
  • In the last couple of years the Gross Margin of HCWC has grown nicely.
  • The Profit Margin and Operating Margin are not available for HCWC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.69%
GM growth 5YN/A
HCWC Yearly Profit, Operating, Gross MarginsHCWC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 -10 20 30

2

2. HCWC Health Analysis

2.1 Basic Checks

  • HCWC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for HCWC remains at a similar level compared to 1 year ago.
  • HCWC has a worse debt/assets ratio than last year.
HCWC Yearly Shares OutstandingHCWC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M
HCWC Yearly Total Debt VS Total AssetsHCWC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • HCWC has an Altman-Z score of 2.17. This is not the best score and indicates that HCWC is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of HCWC (2.17) is worse than 73.68% of its industry peers.
  • The Debt to FCF ratio of HCWC is 3.53, which is a good value as it means it would take HCWC, 3.53 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 3.53, HCWC is doing good in the industry, outperforming 65.79% of the companies in the same industry.
  • HCWC has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of HCWC (1.10) is worse than 68.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 3.53
Altman-Z 2.17
ROIC/WACCN/A
WACC9.91%
HCWC Yearly LT Debt VS Equity VS FCFHCWC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

  • HCWC has a Current Ratio of 0.98. This is a bad value and indicates that HCWC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.98, HCWC is doing worse than 65.79% of the companies in the same industry.
  • A Quick Ratio of 0.53 indicates that HCWC may have some problems paying its short term obligations.
  • HCWC has a Quick ratio of 0.53. This is comparable to the rest of the industry: HCWC outperforms 44.74% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.53
HCWC Yearly Current Assets VS Current LiabilitesHCWC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

6

3. HCWC Growth Analysis

3.1 Past

  • HCWC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.68%, which is quite impressive.
  • The Revenue has grown by 24.57% in the past year. This is a very strong growth!
  • The Revenue has been growing by 83.46% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)52.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.73%
Revenue 1Y (TTM)24.57%
Revenue growth 3Y83.46%
Revenue growth 5YN/A
Sales Q2Q%4.45%

3.2 Future

  • The Earnings Per Share is expected to grow by 24.21% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, HCWC will show a quite strong growth in Revenue. The Revenue will grow by 14.78% on average per year.
EPS Next Y37.14%
EPS Next 2Y24.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year17.67%
Revenue Next 2Y14.78%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
HCWC Yearly Revenue VS EstimatesHCWC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
HCWC Yearly EPS VS EstimatesHCWC Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.1 -0.2 -0.3

2

4. HCWC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for HCWC. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HCWC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HCWC Price Earnings VS Forward Price EarningsHCWC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, HCWC is valued a bit more expensive than 71.05% of the companies in the same industry.
  • HCWC's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HCWC is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.82
EV/EBITDA 28.2
HCWC Per share dataHCWC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

  • HCWC's earnings are expected to grow with 24.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.21%
EPS Next 3YN/A

0

5. HCWC Dividend Analysis

5.1 Amount

  • HCWC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

HCWC Fundamentals: All Metrics, Ratios and Statistics

HEALTHY CHOICE WELLNESS CORP

NYSEARCA:HCWC (3/11/2026, 4:04:07 PM)

After market: 0.2991 +0.01 (+3.53%)

0.2889

+0 (+1.69%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)10-20
Earnings (Next)03-27
Inst Owners3.57%
Inst Owner Change-30.72%
Ins Owners13.7%
Ins Owner Change0%
Market Cap4.35M
Revenue(TTM)79.15M
Net Income(TTM)-2.83M
Analysts82.86
Price Target2.04 (606.13%)
Short Float %0.53%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.76%
Min EPS beat(2)-47.06%
Max EPS beat(2)70.59%
EPS beat(4)3
Avg EPS beat(4)21.22%
Min EPS beat(4)-47.06%
Max EPS beat(4)70.59%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.54%
Min Revenue beat(2)-6.91%
Max Revenue beat(2)5.83%
Revenue beat(4)2
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-6.91%
Max Revenue beat(4)5.83%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF 1.82
P/OCF 1.58
P/B 0.74
P/tB N/A
EV/EBITDA 28.2
EPS(TTM)-0.24
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)0.16
FCFY55.03%
OCF(TTM)0.18
OCFY63.18%
SpS5.25
BVpS0.39
TBVpS-0.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.38%
ROE -47.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.73%
FCFM 3.03%
ROA(3y)-19.39%
ROA(5y)N/A
ROE(3y)-107.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.69%
GM growth 5YN/A
F-Score7
Asset Turnover2.35
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 3.53
Debt/EBITDA 18.91
Cap/Depr 20.56%
Cap/Sales 0.45%
Interest Coverage N/A
Cash Conversion 795.89%
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.53
Altman-Z 2.17
F-Score7
WACC9.91%
ROIC/WACCN/A
Cap/Depr(3y)22.38%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.67%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.73%
EPS Next Y37.14%
EPS Next 2Y24.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)24.57%
Revenue growth 3Y83.46%
Revenue growth 5YN/A
Sales Q2Q%4.45%
Revenue Next Year17.67%
Revenue Next 2Y14.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y53.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.36%
OCF growth 3YN/A
OCF growth 5YN/A

HEALTHY CHOICE WELLNESS CORP / HCWC FAQ

What is the fundamental rating for HCWC stock?

ChartMill assigns a fundamental rating of 3 / 10 to HCWC.


What is the valuation status for HCWC stock?

ChartMill assigns a valuation rating of 2 / 10 to HEALTHY CHOICE WELLNESS CORP (HCWC). This can be considered as Overvalued.


How profitable is HEALTHY CHOICE WELLNESS CORP (HCWC) stock?

HEALTHY CHOICE WELLNESS CORP (HCWC) has a profitability rating of 2 / 10.


What is the financial health of HEALTHY CHOICE WELLNESS CORP (HCWC) stock?

The financial health rating of HEALTHY CHOICE WELLNESS CORP (HCWC) is 2 / 10.


Can you provide the expected EPS growth for HCWC stock?

The Earnings per Share (EPS) of HEALTHY CHOICE WELLNESS CORP (HCWC) is expected to grow by 37.14% in the next year.